ArticleNeurology2026

Postapproval Study for Brain-Responsive Neurostimulation for Drug-Resistant Focal Epilepsy: Three-Year Efficacy and Interim Safety Results.

Dawn Eliashiv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.